1887

Abstract

Mice vaccinated intraperitoneally (i.p.) with 10 p.f.u. of a vaccinia virus recombinant expressing either the glycoprotein (rVac-G) or nucleoprotein (rVac-N) of rabies virus 3 weeks before challenge were protected against peripheral lethal infection. Similarly, by postexposure vaccination in which mice were first infected with rabies virus and subsequently vaccinated i.p. with the recombinant, rVac-G conferred protection when given immediately following infection and up to 24 h after infection. Prior treatment of those mice with anti-CD8 monoclonal antibodies (MAb) did not significantly affect the outcome of the infection. In contrast, rVac-N failed to confer protection even with higher doses (10 p.f.u.) of the virus or even when administered by the intradermal route. Anti-nucleoprotein antibody production by these mice was not suppressed by prior rabies virus infection and the levels and the time of antibody production were similar to those of anti-glycoprotein antibody production in mice vaccinated with rVac-G after rabies virus infection. The cytotoxic T lymphocyte response was also not down-regulated by rabies virus in the mice that were given rVac-N. Possible mechanism(s) for the ineffectiveness of rVac-N by post-exposure vaccination in contrast to pre-exposure vaccination was discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-6-1339
1994-06-01
2022-01-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/6/JV0750061339.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-6-1339&mimeType=html&fmt=ahah

References

  1. Baer G. M., Yager P. A. 1977; A mouse model for post-exposure rabies prophylaxis: the comparative efficacy of two vaccines and of antiserum administration. Journal of General Virology 36:51–58
    [Google Scholar]
  2. Brochier B., Thomas I., Bauduin B., Leveau T., Pastoret P. P., Languet B., Chappuis G., Desmettre P., Blancou J., Artois M. 1990; Use of vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies. Vaccine 8:101–104
    [Google Scholar]
  3. Bunschoten H., Gore M., Claassen I. J. TH. M., Uytdehaag F. G. C. M., Dietzschold B., Wunner W. H., Osterhaus A. D. M. E. 1989; Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. Journal of General Virology 70:291–298
    [Google Scholar]
  4. Chakrabarti S., Brechling K., Moss B. 1985; Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5:3403–3409
    [Google Scholar]
  5. Cho S., Narahara H., Mifune K., Kawai A. 1987; Murine T cell clones directed to rabies virus: isolation and some of their properties. Journal of General Virology 68:1115–1123
    [Google Scholar]
  6. Cox J. H., Dietzschold B., Schneider L. G. 1977; Rabies virus glycoprotein 11. Biological and serological characterization. Infection and Immunity 16:754–759
    [Google Scholar]
  7. Dietzschold B., Wang H., Rupprecht C. E., Celis E., Tollis M., Ertl H., Heber-Katz E., Koprowski H. 1987; Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proceedings of the National Academy of Sciences U.S.A.: 849165–9169
    [Google Scholar]
  8. Dietzschold B., Kao M., Zheng Y. M., Chen Z. Y., Maul G., Fu Z. F., Rupprecht C. E., Koprowski H. 1992; Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proceedings of the National Academy of Sciences U.S.A.: 897252–7256
    [Google Scholar]
  9. Ertl H. C. J., Dietzschold B., Gore M., Otvos L. Jr Larson J. K., Wunner W. H., Koprowski H. 1989; Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein. Journal of Virology 63:2885–2892
    [Google Scholar]
  10. Esposito J. J., Brechling K., Baer G., Moss B. 1987; Vaccinia virus recombinants expressing rabies virus glycoprotein protect against rabies. Virus Genes 1:7–21
    [Google Scholar]
  11. Fekadu M., Sumner J. W., Shaddock J. H., Sanderlin D. W., Baer G. M. 1992; Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein. Journal of Virology 66:2601–2604
    [Google Scholar]
  12. Fu Z. F., Dietzschold B., Schumacher C. L., Wunner W. H., Ertl H., Koprowski H. 1991; Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine. Proceedings of National Academy of Sciences U.S.A.: 882001–2005
    [Google Scholar]
  13. Hirai K., Kawano H., Mifune K., Fujii H., Nishizono A., Shichijo A., Mannen K. 1992; Suppression of cell-mediated immunity by street rabies virus infection. Microbiology and Immunology 36:1277–1290
    [Google Scholar]
  14. Kawano H., Mifune K., Ohuchi M., Mannen K., Cho S., Hiramatsu K., Shichijo A. 1990; Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus. Journal of General Virology 71:281–287
    [Google Scholar]
  15. Kieny M. P., Lathe R., Drillien R., Spehner D., Skory S., Schmitt D., Wiktor T. J., Koprowski H., Lecocq J. P. 1984; Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature; London: 312163–166
    [Google Scholar]
  16. Lafon M., Wiktor T. J., Macfarlan R.I. 1983; Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. Journal of General Virology 64:843–851
    [Google Scholar]
  17. Lodmell D. L., Sumner J. W., Esposito J. J., Bellini W. J., Ewalt L. C. 1991; Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection. Journal of Virology 65:3400–3405
    [Google Scholar]
  18. Lodmell D. L., Esposito J. J., Ewalt L. C. 1993; Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro. Journal of Virology 67:6080–6086
    [Google Scholar]
  19. Mifune K., Shichijo A., Makino Y., Takeuchi E., Yamada A., Sakamoto K. 1980; A mouse model for the pathogenesis and postexposure prophylaxis of rabies. Microbiology and Immunology 24:835–845
    [Google Scholar]
  20. Perry L. L., Lodmell D. L. 1991; Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. Journal of Virology 65:3429–3434
    [Google Scholar]
  21. Prevec L., Campbell J. B., Christie B. S., Belbeck L., Graham F. L. 1990; A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 161:27–30
    [Google Scholar]
  22. Sikes R. K., Clearly W. F., Koprowski H., Wiktor T. J., Kaplan M. M. 1971; Effective protection of monkeys against death by street virus by post-exposure administration of tissue culture rabies vaccine. Bulletin of the World Health Organization 45:1–11
    [Google Scholar]
  23. Smith J. S. 1981; Mouse model for abortive rabies infection of the central nervous system. Infection and Immunity 31:297–308
    [Google Scholar]
  24. Sokol F., Schlumberger H. D., Wiktor T. J., Koprowski H., Hummeler K. 1969; Biochemical and biophysical studies on the nucleocapsid and on the RNA of rabies virus. Virology 38:651–665
    [Google Scholar]
  25. Sumner J. W., Fekadu M., Shaddock J. H., Esposito J. J., Bellini W. J. 1991; Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein. Virology 183:703–710
    [Google Scholar]
  26. Takita-Sonoda Y., Fujii H., Mifune K., Ito Y., Hiraga M., Nishizono A., Mannen K., Minamoto N. 1993; Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection. Archives of Virology 132:51–65
    [Google Scholar]
  27. Thomas I., Brochier B., Languet B., Blancou J., Peharpre D., Kieny M. P., Desmettre P., Chappuis G., Pastoret P.-P. 1990; Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route. Journal of General Virology 71:37–42
    [Google Scholar]
  28. Wiktor T. J., Doherty P. C., Koprowski H. 1977; Suppression of cell-mediated immunity by street rabies virus. Journal of Experimental Medicine 145:1617–1622
    [Google Scholar]
  29. Wiktor T. J., Macfarlan R. I., Reagan K. J., Dietzschold B., Curtis P. J., Wunner W. H., Kieny M. P., Lathe R., Lecocq J. P., Mackett M., Moss B., Koprowski H. 1984; Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proceedings of the National Academy of Sciences U.S.A: 817194–7198
    [Google Scholar]
  30. Wunner W. H., Dietzschold B., Curtis P. J., Wiktor T. J. 1983; Rabies subunit vaccines. Journal of General Virology 64:1649–1656
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-6-1339
Loading
/content/journal/jgv/10.1099/0022-1317-75-6-1339
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error